Approval · Notice of Compliance 5314 · 2004
ZYMAR: Notice of Compliance 5314
Issued August 30, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5314
- Date
- August 30, 2004
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZYMAR | 02257270 | Marketed |
Medicinal ingredients
- GATIFLOXACIN 3 MG per ML